References
- Anderson M. E., Meister A. Dynamic state of glutathione in blood plasma. J. Biol. Chem. 1980; 255(20)9530–9533, [PUBMED], [INFOTRIEVE]
- Appenroth D., Winnefield K. Role of glutathione for cisplatin nephrotoxicity in young and adult rats. Ren. Fail. 1993; 15(2)135–139, [PUBMED], [INFOTRIEVE]
- Appenroth D., Winnefield K., Schroter H., Rost M. Beneficial effect of acetylcysteine on cisplatin nephrotoxicity in rats. J. Appl. Toxicol. 1993; 13(3)189–192, [PUBMED], [INFOTRIEVE], [CSA]
- Banks A. T., Zimmerman H. J., Ishak K. G., Harter J. G. Diclofenac‐associated hepatotoxicity: analysis of 180 cases reported to the food and drug administration as adverse reactions. Hepatology 1995; 22(3)820–827, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cucurull E., Borrellas X., Fort J., Camps J., Piera L. Nephrotoxicity caused by diclofenac. Rev. Clin. Esp. 1994; 194(1)66, [PUBMED], [INFOTRIEVE], [CSA]
- Eaton D. L., Klaassen C. D. Principles of Toxicology. Casarett & Doull's Toxicology: The Basic Science of Poisons5th ed., C. D. Klaassen. McGraw‐Hill Health Professions Division. 1998; 13–33
- Hickey E. J., Raje R. R., Reid V. E., Gross S. M., Ray S. D. Diclofenac induced in vivo nephrotoxicity may involve oxidative stress‐mediated massive genomic DNA fragmentation and apoptotic cell death. Free Radic. Biol. Med. 2001; 31(2)139–152, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ishikawa M., Takayanagi Y., Sasaki K. Enhancement of CP toxicity by buthionine sulfoximine, a glutathione‐depleting agent, in mice. Res. Commun. Chem. Pathol. Pharmacol. 1990; 67(1)131–141, [PUBMED], [INFOTRIEVE]
- Lash L. H. Glutathione and other antioxidant defense mechanisms. Comprehensive Toxicology, R. S. Goldstein. Renal Toxicology, Elsevier Science Ltd, Oxford 1997; Vol 7: 403–428
- Mayer R. D., Lee K. E., Cockett A. T. Inhibition of CP‐induced nephrotoxicity in rats by buthionine sulfoximine, a glutathione synthesis inhibitor. Cancer Chemother. Pharmacol. 1987; 20(3)207–210, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application of proliferation and cytotoxicity assays. J. Immunol. Methods 1983; 65: 55–63, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Parrish A. R., Alejandro N. F., Bowes R. C., III, Ramos K. S. Cytotoxic response profiles of cultured renal epithelial and mesenchymal cells to selected aromatic hydrocarbons. Toxicol. In Vitro 1998; 12: 219–232, [CROSSREF], [CSA]
- Pinzani V., Bressolle F., Haug I. J., Galtier M., Blayac J. P., Balmes P. cisplatin induced renal toxicity and toxicity‐modulating strategies: a review. Cancer Chemother. Pharmacol. 1994; 35(1)1–9, [PUBMED], [INFOTRIEVE], [CSA]
- Rosenberg B. Fundamental studies with CP. Cancer 1985; 55(10)2303–2316, [PUBMED], [INFOTRIEVE]
- Seglen P. O. Preparation of isolated rat liver cells. Methods Cell Biol. 1975; 13: 29–83
- Suzuki C. A., Cherian M. G. The interactions of cis‐diaminedichloroplatinum with metallothionein and glutathione in rat liver and kidney. Toxicology 1990; 64(2)113–127, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zicca A., Cafaggi S., Mariggio M. A., Vannozzi M. O., Ottone M., Bocchini V., Caviglioli G., Viale M. Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats. Eur. J. Pharmacol. 2002; 442(3)265–272, [PUBMED], [INFOTRIEVE], [CROSSREF]